期刊
CELL BIOLOGY INTERNATIONAL
卷 47, 期 4, 页码 742-753出版社
WILEY
DOI: 10.1002/cbin.11978
关键词
ascorbic acid; breast cancer stem cells; cancer stem cells therapeutics; Oct-4 transcription factor; POUF5; siRNA
类别
Breast cancer is a deadly and frequently diagnosed metastatic cancer, and cancer stem cells play a crucial role in its progression. This study identified Oct-4 as a promising marker for survival in breast cancer stem cells (bCSCs) and found that Oct-4 knockdown induced cell death and inhibited mammosphere formation. The study also suggests a direct interaction between Oct-4 and Vitamin C. These findings contribute novel information about Oct-4 as a survival factor in bCSCs.
Breast cancer (BC) remains one of the deadliest and frequently diagnosed metastatic cancers worldwide. Cancer stem cells (CSCs) are the cell population within the tumor niche, having an epithelial to mesenchymal (EMT) transition phenotype, high self-renewal, vigorous metastatic capacity, drug resistance, and tumor relapse. Identification of targets for induction of apoptosis is essential to provide novel therapeutic approaches in BC. Our earlier studies showed that Vitamin C induces apoptotic cell death by losing redox balance in TNBC CSCs. In this study, we have attempted to identify previously unrecognized CSC survival factors that can be used as druggable targets for bCSCs apoptosis regulators isolated from the TNBC line, MDA MB 468. After a thorough literature review, Oct-4 was identified as the most promising marker for its unique abundance in cancer and absence in normal cells and the contribution of Oct-4 to the sustenance of cancer cells. We then validated a very high expression of Oct-4 in the MDA MB 468 bCSCs population using flow-cytometry. The loss of Oct-4 was carried out using small interfering RNA (siRNA)-mediated knockdown in the bCSCs, followed by assessing for cellular apoptosis. Our results indicated that Oct-4 knockdown induced cell death, changes in cellular morphology, inhibited mammosphere formation, and positive for Annexin-V expression, thereby indicating the role of Oct-4 in bCSC survival. Moreover, our findings also suggest the direct interaction between Oct-4 and Vitamin C using in silico docking. This data, hence, contributes towards novel information about Oct-4 highlighting this molecule as a novel survival factor in bCSCs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据